RxDoctor Payments Data

Kevin Cross, MD

Plastic and Reconstructive Surgery · Wayne, PANPI 1144436403

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.2% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 44.9% of the total. Reporting peaked in 2019 at $1,111 and has fallen 83.5% since, to $183 in 2025.

$4,112in general payments, 2019–2025

Across 170 payments — averaging $24.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Merz North America, Inc.$1K
  • Siemens Medical Solutions USA, Inc.$301
  • Sientra, Inc.$155
  • Galderma Laboratories, L.p.$99
  • Motiva USA, LLC$66
  • plus $146 from 5 others

What the payments were for

  • Travel & lodging$2316%
  • Food & beverage$3,83293%
  • Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,112 in reported general payments places this provider in the 70th percentile of 108 plastic and reconstructive surgery providers in Pennsylvania.

See all plastic and reconstructive surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$18,348
Medicare patients
16
Services billed
26

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aprepitant17$753
Gabapentin93$440
ValacyclovirValacyclovir Hcl28$421
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha46$379
Minoxidil15$207
Ondansetron OdtOndansetron44$192
Mupirocin19$164
Hydromorphone Hcl31$126
Methylprednisolone18$108
ErythromycinErythromycin Base12$102
Diazepam32$82
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$63
Clonidine Hcl17$21

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Wayne

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →